Osteopontin Expression Correlates with Clinical Outcome in Patients with Mycobacterial Infection
- 1 July 2000
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 157 (1) , 37-42
- https://doi.org/10.1016/s0002-9440(10)64514-2
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Eta-1 (Osteopontin): An Early Component of Type-1 (Cell-Mediated) ImmunityScience, 2000
- Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection.Journal of Clinical Investigation, 1998
- Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection.Journal of Clinical Investigation, 1998
- Impairment of Mycobacterial Immunity in Human Interleukin-12 Receptor DeficiencyScience, 1998
- Severe Mycobacterial and Salmonella Infections in Interleukin-12 Receptor-Deficient PatientsScience, 1998
- Altered wound healing in mice lacking a functional osteopontin gene (spp1).Journal of Clinical Investigation, 1998
- Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis.Journal of Clinical Investigation, 1997
- Disseminated tuberculosis in interferon gamma gene-disrupted mice.The Journal of Experimental Medicine, 1993
- Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo.The Journal of Experimental Medicine, 1990
- Localization of the mouse gene for secreted phosphoprotein 1 (Spp-1) (2ar, osteopontin, bone sialoprotein 1, 44-kDa bone phosphoprotein, tumor-secreted phosphoprotein) to chromosome 5, closely linked to Ric (Rickettsia resistance)Genomics, 1989